Skip to main content
. 2022 Jan 18;98(3):e302–e314. doi: 10.1212/WNL.0000000000013055

Figure 2. Association Between Alteplase Treatment and Functional Outcome at 90 Days According to Presence and Spatial Distribution of CMBs.

Figure 2

Point estimates >1 indicate better functional outcome with alteplase treatment. *First p value per group corresponds to the hypothesis that across patients with any number of cerebral microbleeds (CMBs), the odds ratio (OR) is equal to 1 (no effect); the second p value corresponds to the hypothesis that within strata of patients with no CMBs and ≥1 CMBs, the OR is identical (no interaction). CAA = cerebral amyloid angiopathy; CI = confidence interval; mRS = modified Rankin Scale.